Drugmaker AstraZeneca to acquire EsoBiotec for $1 billion Biotechnology March 17, 2025 The transaction is expected to close in the second quarter of 2025, which will include AstraZeneca will buying all outstanding equity in EsoBiotec on a cash and debt-free basis